BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 173 filers reported holding BLUEBIRD BIO INC in Q2 2023. The put-call ratio across all filers is 2.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,526 | -71.3% | 480 | -37.6% | 0.00% | – |
Q4 2022 | $5,321 | +6.4% | 769 | -1.9% | 0.00% | – |
Q3 2022 | $5,000 | +150.0% | 784 | +57.7% | 0.00% | – |
Q2 2022 | $2,000 | +100.0% | 497 | +2661.1% | 0.00% | – |
Q2 2020 | $1,000 | -80.0% | 18 | -83.9% | 0.00% | -100.0% |
Q1 2020 | $5,000 | +150.0% | 112 | +489.5% | 0.00% | 0.0% |
Q4 2019 | $2,000 | – | 19 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AlpInvest Partners B.V. | 46,264 | $3,958,000 | 7.80% |
RTW INVESTMENTS, LP | 151,594 | $12,969,000 | 4.03% |
APIS CAPITAL ADVISORS, LLC | 30,870 | $2,640,000 | 3.65% |
Parametrica Management Ltd | 4,084 | $349,000 | 2.20% |
Eventide Asset Management | 419,600 | $35,897,000 | 2.09% |
RA Capital Management | 167,367 | $14,318,000 | 2.06% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 483,000 | $41,321,000 | 1.60% |
Taylor Wealth Management Partners | 38,184 | $3,267,000 | 1.58% |
Orbimed Advisors | 1,188,900 | $101,710,000 | 1.03% |
CABOT WEALTH MANAGEMENT INC | 34,195 | $2,925,000 | 0.81% |